Wealth Enhancement Advisory Services LLC Acquires New Shares in Sotera Health (NASDAQ:SHC)

Wealth Enhancement Advisory Services LLC bought a new stake in Sotera Health (NASDAQ:SHC - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 50,893 shares of the company's stock, valued at approximately $850,000.

Other large investors have also recently bought and sold shares of the company. CWM LLC raised its position in shares of Sotera Health by 86.1% during the second quarter. CWM LLC now owns 2,146 shares of the company's stock worth $25,000 after acquiring an additional 993 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock worth $50,000 after acquiring an additional 1,660 shares during the last quarter. Point72 DIFC Ltd raised its position in shares of Sotera Health by 556.6% during the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company's stock worth $78,000 after acquiring an additional 5,544 shares during the last quarter. Acadian Asset Management LLC raised its position in shares of Sotera Health by 728.0% during the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company's stock worth $111,000 after acquiring an additional 8,248 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Sotera Health during the third quarter worth about $163,000. 91.03% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

SHC has been the subject of a number of research analyst reports. Citigroup lifted their target price on Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a report on Wednesday. Royal Bank of Canada reiterated an "outperform" rating and issued a $17.00 target price on shares of Sotera Health in a report on Tuesday, August 6th. Finally, Barclays lifted their target price on Sotera Health from $14.00 to $17.00 and gave the stock an "overweight" rating in a report on Tuesday, August 6th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Sotera Health presently has a consensus rating of "Moderate Buy" and an average target price of $16.50.

Sotera Health Stock Down 1.7 %

Shares of NASDAQ:SHC traded down $0.28 during mid-day trading on Thursday, hitting $15.83. 1,349,204 shares of the company traded hands, compared to its average volume of 1,307,183. The stock has a market cap of $4.48 billion, a P/E ratio of 63.40 and a beta of 2.08. The company has a current ratio of 2.93, a quick ratio of 2.59 and a debt-to-equity ratio of 5.46. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The stock has a 50-day moving average price of $15.96 and a two-hundred day moving average price of $13.69.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million for the quarter, compared to analysts' expectations of $278.64 million. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The firm's quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.18 EPS. On average, equities research analysts forecast that Sotera Health will post 0.64 earnings per share for the current year.

Insider Activity at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business's stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares of the company's stock, valued at approximately $739,705,974.03. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 55.12% of the stock is owned by insiders.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.